The end product is not only physical protein, but also multiple layers of rich and actionable data that informs the protein synthesis workflow.
Berkeley, United States
Founded in 2015
1-10 Employees
Working industry
Biotechnology
Type of company
-
Locations
1 Headquarter
Number of products
1 Product
Specialised areas
Biotechnology, Health Care, Life Science, Pharmaceutical
Tierra Biosciences, Inc. offers a wide range of products and services
Product
Your Custom Proteins. Pure and Simple. | Tierra Biosciences
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Get insights into the use cases of Tierra Biosciences, Inc.
Use case
Difficult-to-Express Proteins | Applications | Tierra Biosciences | Tierra Biosciences
Tierra uses cell-free expression systems to provide unique paths to production of proteins difficult-to-express with traditional cellular methods
Use case
Computationally Designed Proteins | Applications | Tierra Biosciences | Tierra Biosciences
Test computational designs and discover properties of your protein with Tierra. See why we synthesize custom proteins when library approaches are insufficient.
Tierra Biosciences, Inc. operates in 1 country around the world
Get an overview of the locations of Tierra Biosciences, Inc.
Location
Country
State
City
Headquarter
United States
California
Berkeley
Some frequent questions that have been asked about Tierra Biosciences, Inc.
Where is Tierra Biosciences, Inc. located?
The company headquarter of Tierra Biosciences, Inc. is located in Berkeley, California, United States. It's worth noting, that the company may have more locations
How many employees does Tierra Biosciences, Inc. approximately have?
As of the latest available information Tierra Biosciences, Inc. has around 1-10 employees worldwide.
When was Tierra Biosciences, Inc. founded?
Tierra Biosciences, Inc. was founded in 2015
In which industries does Tierra Biosciences, Inc. mainly work?
The company Tierra Biosciences, Inc. has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to Tierra Biosciences, Inc.
Adaptyv Bio
Lausanne, Switzerland
11-50 Employees
-
This data provides feedback and augments the AI models at each round in order to optimize the functional profile of the next set of protein designs. Our foundry is being built from the ground up to integrate with AI at every step of the protein engineering cycle - from designing sequences, to planning experimental protocols, to running those experiments autonomously and tracking all data and metadata.
Protera
Santiago, Chile
11-50 Employees
2018
We are building the next generation of functional ingredients for the food industry using protein engineering and artificial intelligence. Our unique approach allows us to deliver protein ingredients with unmatched performance. To turn that protein into a viable product, it is necessary to ensure it will work on the target conditions, including high-temperature, low-ph, etc. We recently integrated into madi™, the world's most advanced protein production prediction engine. This unique capability provides our team the power to maximize the success rate and develop a highly effective and commercially viable product. They are also nutritious and provide incredible functionalities.
Proteome Sciences
London, United Kingdom
11-50 Employees
1993
Our proteomics expertise provides complementary and enabling content and insight for our customers to develop more effective, time and cost-efficient healthcare solutions. To enable targeted therapeutics by delivering innovative proteomic services.
Scotia Biologics
Aberdeen City, United Kingdom
1-10 Employees
2012
To provide the highest quality of service and to build strong partnerships, focusing on development of cutting-edge technologies in expression, production, and manufacturing of recombinant proteins and antibodies. Our team of scientists have extensive experience and wide-ranging expertise in protein production, purification and validation. Using the information provided through consultation with our project manager, we will develop a project plan carefully designed to maximise the likelihood of a successful outcome. This plan will be continually reviewed and refined as the project progresses. Deliverables can be as simple as crude polyclonal antibody (sera), or include purified protein, genetic information (antibody V-gene sequences), plasmids/bacterial glycerols, cell lines, or even detailed protein characterisation (ELISA, WB, functional assays, BIAcore analysis etc.). All deliverables are the sole property of the customer, and there are no royalties or retained ownership. The antibody service that provides you with the exact antibody you need to test and validate your target so you can progress your research projects without wasting months working through catalogue or polyclonal antibody options.
Infinite Enzymes
Jonesboro, United States
1-10 Employees
2006
Our industry-redefining proteins can meet growing demand within established markets while unlocking transformational growth through breakthrough applications. Our platform can scale production up or down with ease, helping meet a wide variety of demands along with delivering just-in-time manufacturing capabilities. By nature, our proprietary technology and processes drive exponentially sustainable protein production while also unlocking new protein-based greening opportunities. We start by optimizing and growing proteins using proprietary processes that enable industry-leading accumulation rates.Our plant-based technology has a ~96% success rate for commercially viable implantation. We produce proteins directly inside the corn kernel.By eliminating the need for a fermentation facility we save >$100MM in upfront costs, drive greener production, and reduce overhead.
Bioprocess
Sydney, Australia
- Employees
-
All steps from conceptualizing a gene product of interest, genetically engineering a suitable construct, expressing, purifying and evaluating the product are typically performed in-house, with the evaluation step frequently accomplished as a collaborative effort with outside partners. Primary attention to date has been directed towards the development of source ingredients for diagnostic purposes, however, the current focus is evolving towards the generation of recombinant polypeptides useful in other areas of the life sciences pursuant to the dramatically widened interest in, and need for, novel proteins in the wake of the expansion of genomics in general. You are invited to click on topics of interest in the Products page to review, in greater detail, the subject matter of your choice. ABN 48 119 510 173 Suite 145, Cicada Innovations, Australian Technology Park,. 4 Cornwallis Street Eveleigh, NSW 2015, AUSTRALIA Phone Number +61 2 9209 4086.